Reproductive biology and IVF: ovarian stimulation and luteal phase consequences

被引:166
作者
Fauser, BCJM
Devroey, P
机构
[1] Erasmus MC, Ctr Reprod Med, NL-3015 GD Rotterdam, Netherlands
[2] Vrije Univ Brussels, Univ Hosp, Ctr Reprod Med, Brussels, Belgium
关键词
D O I
10.1016/S1043-2760(03)00075-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most clinicians working in in vitro fertilization (IVF) centers worldwide have taken for granted for more than a decade the paradigm of so-called 'controlled' ovarian hyperstimulation, using maximum stimulation by exogenous gonadotropins, together with the gonadotropin-releasing hormone (GnRH) agonist long-protocol. Potential detrimental effects of this approach with regard to oocyte quality, corpus luteum function and endometrial receptivity have been largely ignored. These factors might by themselves have a major impact on IVF outcome and should therefore be considered seriously. The recent introduction of GnRH antagonists along with the current emphasis on the need for transfer of a reduced number of embryos enables a careful re-evaluation of current IVF strategies. We can now render stimulation protocols simpler, starting with a spontaneous menstrual cycle, allowing for more subtle interference with single dominant follicle selection. Here, we discuss recent approaches to ovarian stimulation, the induction of oocyte maturation, and effects of these altered follicular phase interventions on corpus luteum function following ovarian stimulation.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 67 条
[1]   GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[2]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[3]   Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve [J].
Bancsi, LFJMM ;
Broekmans, FJM ;
Eijkemans, MJC ;
de Jong, FH ;
Habbema, JDF ;
te Velde, ER .
FERTILITY AND STERILITY, 2002, 77 (02) :328-336
[4]  
BECKERS NG, 2002, HUM REPROD, pO157
[5]   Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging [J].
Beckers, NGM ;
Macklon, NS ;
Eijkemans, MJC ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2002, 78 (02) :291-297
[6]   First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization [J].
Beckers, NGM ;
Macklon, NS ;
Devroey, P ;
Platteau, P ;
Boerrigter, PJ ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2003, 79 (03) :621-623
[7]  
Borm G, 2000, HUM REPROD, V15, P1490
[8]   Gonadotropin-releasing hormone antagonist: new tools vs. old habits [J].
Bouchard, P ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2000, 73 (01) :18-20
[9]  
CASPER RF, 1979, SCIENCE, V205, P408, DOI 10.1126/science.377491
[10]   An international survey of the health economics of IVF and ICSI [J].
Collins, JA .
HUMAN REPRODUCTION UPDATE, 2002, 8 (03) :265-277